Contraceptive injections: Period Changes and Return to Fertility

Contraceptive injections release progestogen and prevent ovulation. Depending on the product, repeat doses are usually due every eight to thirteen weeks. The schedule matters: protection can be affected when the next injection is late.

Prepare for a changing bleeding pattern

Bleeding may become irregular, last longer, or stop. Having no periods becomes more common with continued use. A pattern that is acceptable to one person may be frustrating to another, so explain the effect on your daily life when discussing whether to continue.

Do not assume new heavy bleeding or persistent troublesome symptoms are always caused by the injection. Ask for assessment when the pattern changes or becomes difficult. The breakthrough bleeding guide can help you describe the change clearly.

Keep the next dose date visible

Record the product name and your next appointment. Some products can be self administered after training, but their timing still needs to be followed. If a dose is late, use condoms or avoid sex that could cause pregnancy and contact the clinic promptly for instructions.

Mention any recent sex and ask whether emergency contraception or a pregnancy test is needed. A test taken too early may miss a pregnancy. When period dates are not useful, testing at least three weeks after the relevant unprotected sex is a practical reference point.

Discuss future pregnancy plans before another dose

Unlike an implant or coil, an injection cannot be removed once given. Fertility may take up to a year to return after stopping, although timing varies. That possible delay does not provide a reliable contraception plan after a dose becomes overdue.

If you hope to conceive soon, compare options before the next injection. The method comparison guide explains alternatives that can be removed when your plans change.

Review benefits and risks over time

Discuss weight changes and bone health, particularly with continued use. A review after two years is an opportunity to reassess suitability, not an automatic instruction that everyone must stop.

Medroxyprogesterone injections carry a small increased risk of meningioma, a usually benign tumor around the brain, particularly after prolonged use. These injections should not be used for contraception with a current or previous meningioma. Tell the prescriber about that history and ask how current safety advice affects your choice. This concern should not be generalized to every contraceptive hormone.